Literature DB >> 11420697

Global analysis of differential gene expression after transformation with the v-H-ras oncogene in a murine tumor model.

R Brem1, U Certa, M Neeb, A P Nair, C Moroni.   

Abstract

Mouse PB-3c mast cells stably transfected with the v-H-ras oncogene induce tumor formation in vivo when implanted into mice. Such tumor cells are characterized by an autocrine IL-3 loop. DNA microarrays allow simultaneous transcript imaging of several thousand genes and the technique was applied in this tumor model to analyse gene expression following malignant transformation. Using three independent tumor lines derived from the same precursor the expression of about 400 out of 11 000 genes was modulated in each tumor. A subset of only 75 genes (0.68%) is shared and up- or downregulated in all three lines. A significant portion of this gene pool possesses functions related to tumorigenesis such as cell adhesion, signaling or transcriptional regulation. Apart from a number of expressed sequence tags (EST's) we find downregulation of four interferon-inducible genes in the tumor lines. Finally, when we extrapolate our data to the complete mouse genome, we estimate that about 500 genes are differentially expressed in tumor cells compared to the precursor cell PB-3c.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420697     DOI: 10.1038/sj.onc.1204403

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Transcriptomal profiling of site-specific Ras signals.

Authors:  Lorena Agudo-Ibáñez; Fátima Núñez; Fernando Calvo; Inmaculada M Berenjeno; Xosé R Bustelo; Piero Crespo
Journal:  Cell Signal       Date:  2007-07-04       Impact factor: 4.315

2.  Functional specificity of ras isoforms: so similar but so different.

Authors:  Esther Castellano; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

3.  Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.

Authors:  Karsten Jürchott; Ralf-Jürgen Kuban; Till Krech; Nils Blüthgen; Ulrike Stein; Wolfgang Walther; Christian Friese; Szymon M Kiełbasa; Ute Ungethüm; Per Lund; Thomas Knösel; Wolfgang Kemmner; Markus Morkel; Johannes Fritzmann; Peter M Schlag; Walter Birchmeier; Tammo Krueger; Silke Sperling; Christine Sers; Hans-Dieter Royer; Hanspeter Herzel; Reinhold Schäfer
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

4.  Stem cell gene expression changes induced specifically by mutated K-ras.

Authors:  Feijun Luo; Rifat Hamoudi; David G Brooks; Charles E Patek; Mark J Arends
Journal:  Gene Expr       Date:  2007

5.  Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.

Authors:  Sophie Vasseur; Cédric Malicet; Ezequiel L Calvo; Claude Labrie; Patrice Berthezene; Jean Charles Dagorn; Juan Lucio Iovanna
Journal:  Mol Cancer       Date:  2003-03-19       Impact factor: 27.401

6.  Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS.

Authors:  Iwona Stelniec-Klotz; Stefan Legewie; Oleg Tchernitsa; Franziska Witzel; Bertram Klinger; Christine Sers; Hanspeter Herzel; Nils Blüthgen; Reinhold Schäfer
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

7.  Serum-dependent transcriptional networks identify distinct functional roles for H-Ras and N-Ras during initial stages of the cell cycle.

Authors:  Esther Castellano; Carmen Guerrero; Alejandro Núñez; Javier De Las Rivas; Eugenio Santos
Journal:  Genome Biol       Date:  2009-11-06       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.